Black Bird Biotech Inc (BBBT)

Black Bird Biotech Inc is a common stock listing on OTC Markets. The company develops and sells biotech- and hemp-related products, including MiteXstream, a plant-based biopesticide designed to address spider mites. Its product range also includes CBD oils, gummies and pet treats, CBD-infused personal care items, and hand sanitizer sold under the Grizzly Creek Naturals brand. In addition, Black Bird Biotech grows industrial hemp through the Montana Hemp pilot program. The company, formerly known as Digital Development Partners, Inc., adopted its current name in June 2021 and is based in Argyle, Texas.


Jump directly to the stock analysis sections supported by the latest available data.

Data update note: Fair value and stock analysis metrics are updated after regular market sessions when new data becomes available.
Ticker Fair Value Analyst Price Target Analyst Target Upside/Downside Overall Financial Health Dividend Yield Next Earnings Date Market Cap
OTC-BBBT
Not available
Not available
Not available
Weak
0.0%
November 20, 2026
3.728 K
Valuation • Fair Value

Black Bird Biotech Inc (OTC-BBBT) Fair Value by Valuation Model

No usable valuation estimate is currently available for Black Bird Biotech Inc (OTC-BBBT); fair value and analyst target coverage statuses are shown explicitly below.

Primary Valuation Read

Fair Value

Not available

Data is currently unavailable.

Analyst Price Target

Not available

Data is currently unavailable.

How to read these valuation models

No usable valuation estimate is currently available for Black Bird Biotech Inc (OTC-BBBT). Fair value and the analyst target remain visible as coverage-status fields and should not be read as valuation signals while unavailable.

Profitability • Growth

Profitability & Growth for Black Bird Biotech Inc (OTC-BBBT)

Review the profitability and growth indicators currently supported by the latest data.

EBITDA

0 K

Current operating profitability reference.

How to read profitability and growth

This section helps investors review Black Bird Biotech Inc (OTC-BBBT) from an operating perspective by combining current scale, forward revenue expectations and EBITDA-related profitability measures.

Quality • Risk

Quality & Financial Risk for Black Bird Biotech Inc (OTC-BBBT)

Review the financial quality and risk indicators currently supported by the latest data.

Financial Health

Weak

Financial pressure deserves closer review.

How to read quality and risk

This section combines quality, balance-sheet and accounting-risk indicators for Black Bird Biotech Inc (OTC-BBBT). Read the metrics together: no single score is a complete investment conclusion, but the combined view can highlight financial strength, earnings quality and areas that may deserve closer review.

Events • Dividends

Upcoming Events & Dividends for Black Bird Biotech Inc (OTC-BBBT)

Track the upcoming dates and dividend metrics currently supported by the latest data.

Next Earnings Date

November 20, 2026

Days to Earnings

63

Dividend Yield

0.0%

No current dividend yield is indicated.

How to read events and dividends

This section helps investors track time-sensitive items for Black Bird Biotech Inc (OTC-BBBT), including the next earnings date and dividend-related milestones. These items can matter for short-term volatility, income planning and event-driven positioning.

Technical Outlook

Technical Signals by Time Frame

Review the technical signals currently available for this stock across supported time frames.

Technical Signals by Time Frame

Switch between time frames to review the current technical signal for the stock.

Strong Sell Sell Neutral Buy Strong Buy
Time frame: daily • daily
Neutral

The daily technical read for Black Bird Biotech Inc (OTC-BBBT) is currently Neutral. Use it as a timing signal only, and compare it with valuation, fundamentals and upcoming events before drawing a broader view.

Strong Sell Sell Neutral Buy Strong Buy
Time frame: weekly • weekly
Sell

The weekly technical read for Black Bird Biotech Inc (OTC-BBBT) is currently Sell. Use it as a timing signal only, and compare it with valuation, fundamentals and upcoming events before drawing a broader view.

Strong Sell Sell Neutral Buy Strong Buy
Time frame: monthly • monthly
Sell

The monthly technical read for Black Bird Biotech Inc (OTC-BBBT) is currently Sell. Use it as a timing signal only, and compare it with valuation, fundamentals and upcoming events before drawing a broader view.

FAQ Fast Investor Answers

Black Bird Biotech Inc (OTC-BBBT) Stock FAQ

Data-supported answers about Black Bird Biotech Inc (OTC-BBBT), including explicit coverage status where a reliable valuation estimate is not currently available.

Fair Value
Not available
No reliable estimate from the currently supported inputs
Financial Health
Weak
Current financial-health read

A reliable fair value estimate is not currently available for Black Bird Biotech Inc (OTC-BBBT). This generally means the latest dataset does not contain enough valid inputs for the valuation models supported by PriceToWorth. The site does not substitute zero or publish an unsupported estimate; availability may change when updated financial data or applicable model inputs become available.

The current financial health read for Black Bird Biotech Inc (OTC-BBBT) is Weak. This should be reviewed alongside valuation, profitability, debt and cash-flow quality metrics.

The next earnings date currently listed for Black Bird Biotech Inc (OTC-BBBT) is November 20, 2026.

The latest available data indicates no current dividend yield for Black Bird Biotech Inc (OTC-BBBT).

The current market capitalization listed for Black Bird Biotech Inc is 3.728 K.

The ticker symbol for Black Bird Biotech Inc is OTC-BBBT, and the stock is listed on OTC Markets.

Black Bird Biotech Inc (OTC-BBBT) is listed on OTC Markets.